Medicare Patients Don’t Need More Information —They Need Someone to Act
The assumption is intuitive and well-intentioned: if patients simply understood the system better, they would use it more effectively. However, for most Medicare patients, that assumption is wrong. The barrier to care isn't knowledge, it's execution.
The Hidden Million-Dollar Problem Lurking in Hospital Operations
As the industry continues to pour money into AI and other emerging technologies, a more disciplined era of healthcare technology investment is taking shape.
Oura Files for IPO As Healthcare Ambitions Grow
Oura has filed for an IPO as it looks to build on its evolution from a sleep-focused wearable startup into a broader healthcare player.
Employers are Scaling AI Use in Health Benefits, but Face Challenges
A new WTW survey found that employers are rapidly adopting AI in health benefits despite concerns about governance, resources, privacy and compliance.
Eli Lilly’s Vaccine Acquisitions Signal a Strategy of Growth in New Areas
Eli Lilly is spending up to $3.8 billion to buy vaccines in development for shingles, staph infections, and Epstein-Barr virus as well as the platform technologies that spawned these programs. The pharmaceutical giant indicated interest in infectious disease last year when it hired Peter Marks, former director of the FDA division that oversees vaccines.